Clinical Trial Update: A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 study completed that compared the time to onset of action of two doses of vardenafil (10 mg and 20 mg) with placebo in men with erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Levitra (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED